ODP154 Reduction of Cardiac Adipose Tissue Volume with Short-Term Empagliflozin in Patients with Type 2 Diabetes: Results from the SIMPLE Randomized Clinical Trial

por Brandt-Jacobsen, Niels, Jürgens, Mikkel, Hasbak, Phillip, Gæde, Peter, Rossing, Peter, Rasmussen, Jon, Andersen, Camillla Fuchs, Forman, Julie, Faber, Jens, Inzucchi, Silvio, Gustafsson, Finn, Schou, Morten, Kistorp, Caroline
Publicado 2022

Design of a randomised controlled trial of the effects of empagliflozin on myocardial perfusion, function and metabolism in type 2 diabetes patients at high cardiovascular risk (th...

por Jürgens, Mikkel, Schou, Morten, Hasbak, Philip, Kjær, Andreas, Wolsk, Emil, Zerahn, Bo, Wiberg, Mikkel, Brandt, Niels Høgh, Gæde, Peter Haulund, Rossing, Peter, Faber, Jens, Inzucchi, Silvio, Gustafsson, Finn, Kistorp, Caroline Michaela
Publicado 2019

Effects of Empagliflozin on Myocardial Flow Reserve in Patients With Type 2 Diabetes Mellitus: The SIMPLE Trial

por Jürgens, Mikkel, Schou, Morten, Hasbak, Philip, Kjær, Andreas, Wolsk, Emil, Zerahn, Bo, Wiberg, Mikkel, Brandt‐Jacobsen, Niels H., Gæde, Peter, Rossing, Peter, Faber, Jens, Inzucchi, Silvio E., Gustafsson, Finn, Kistorp, Caroline
Publicado 2021

Reduction of cardiac adipose tissue volume with short‐term empagliflozin treatment in patients with type 2 diabetes: A substudy from the SIMPLE randomized clinical trial

por Brandt‐Jacobsen, Niels H., Jürgens, Mikkel, Hasbak, Philip, Gæde, Peter, Rossing, Peter, Rasmussen, Jon J., Andersen, Camillla Fuchs, Forman, Julie L., Faber, Jens, Inzucchi, Silvio E., Gustafsson, Finn, Schou, Morten, Kistorp, Caroline
Publicado 2023